Perioperative Immunotherapy for NSCLC (ECTOP-1030)
Phase 2
Not yet recruiting
- Conditions
- Lung Cancer
- Registration Number
- NCT06572722
- Lead Sponsor
- Fudan University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Inclusion Criteria:<br><br> 1. Patients who sign the informed consent form and are willing to complete the study<br> according to the plan;<br><br> 2. Aged from 18 to 80 years old;<br><br> 3. ECOG equals 0 or 1;<br><br> 4. Not receiving lung cancer surgery before;<br><br> 5. Resectable cIB-IIIA tumors;<br><br> 6. Not receiving chemotherapy or radiotherapy before.<br><br>Exclusion Criteria:<br><br> 1. Not cIB-IIIA tumors;<br><br> 2. Nodules not suitable for resection;<br><br> 3. Not lung adenocarcinoma diagnosed cytologically or pathologically;<br><br> 4. Receiving lung cancer surgery before;<br><br> 5. Receiving radiotherapy or chemotherapy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease-free survival
- Secondary Outcome Measures
Name Time Method Overall survival;Major pathological response